Cyproheptadine for Horses: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Cyproheptadine is a prescription antihistamine with strong anti-serotonin effects. In horses, it is used off-label, which means your vet may prescribe it even though it is not specifically FDA-approved for equine use. Its serotonin-blocking action is the main reason it is considered in certain endocrine and neurologic-style problems.

In equine medicine, cyproheptadine is most often discussed as a medication for pituitary pars intermedia dysfunction (PPID, sometimes called equine Cushing's disease) and for some horses with headshaking syndrome. It is not usually the first medication reached for in every case, and response can be variable. That is why your vet will usually match the plan to your horse's diagnosis, age, other medications, and treatment goals.

Because horses are large patients and tablet strengths are small, dosing often involves multiple tablets or a compounded preparation. Your vet may also adjust the plan over time based on clinical response, lab work, and how easy the medication is for you to give consistently.

The most common use of cyproheptadine in horses is as an adjunct or alternative medication for PPID. Older reports and reviews describe it as a serotonin antagonist that may reduce stimulation of the pars intermedia, but published results have been mixed. In many horses with PPID, pergolide remains the more common first-line medication, while cyproheptadine may be considered when response is incomplete, when combination therapy is being explored, or when your vet has a specific reason to try it.

Cyproheptadine is also used in some horses with headshaking, especially when the pattern suggests a seasonal, photic, allergic, or trigeminal-mediated component. It does not help every horse. Headshaking has many possible causes, so your vet usually needs to rule out dental disease, sinus or airway disease, eye pain, ear disease, tack issues, and other sources of discomfort before deciding whether a medication trial makes sense.

Less commonly, veterinary references mention cyproheptadine in selected behavioral or estrus-related situations because serotonin pathways can influence behavior and hormone signaling. These uses are more individualized and should be guided closely by your vet, especially if the horse is pregnant, breeding, competing, or taking other neurologic, sedative, or endocrine medications.

Cyproheptadine dosing in horses varies by the condition being treated and by your vet's preferred protocol. Published equine references commonly describe PPID doses around 0.25 mg/kg by mouth once daily, while some formularies and reviews list 0.3 to 0.5 mg/kg or, historically, 0.6 to 1.2 mg/kg in certain reports. For headshaking, references commonly describe about 0.3 mg/kg by mouth every 12 hours. These ranges are broad, which is one reason this medication should only be used under veterinary direction.

For a 500 kg horse, even a modest dose can require many 4 mg tablets, so your vet may recommend a compounded form, tablet splitting, or a carefully structured administration plan. Do not change the dose on your own if your horse seems sleepy or if signs are not improving. Some horses need a gradual adjustment, while others need a different medication entirely.

Give cyproheptadine exactly as your vet prescribes. If you miss a dose, ask your vet or pharmacist what to do rather than doubling the next dose. Horses with liver disease, glaucoma risk, urinary retention concerns, or a history of sensitivity to sedating medications may need extra caution. If the medication is being used for PPID, your vet may also recommend follow-up exams and ACTH monitoring to see whether the treatment plan is actually helping.

Reported side effects in horses appear to be uncommon but possible. The most often mentioned adverse effect is drowsiness or sedation, especially at higher doses. Some references also note that marked sleepiness or even stupor can occur if the dose is too high or if the horse is unusually sensitive.

Because cyproheptadine also has anticholinergic activity, your vet may watch for dry mucous membranes, reduced gut sounds, slower manure output, or urinary difficulty in susceptible horses. Those effects are not reported in every horse, but they matter because horses are sensitive to changes in gastrointestinal motility.

Call your vet promptly if you notice heavy sedation, worsening depression, poor appetite, fewer manure piles, signs of colic, trouble urinating, or any sudden change after starting the medication. If your horse becomes severely dull, painful, or shows colic signs, see your vet immediately. A medication side effect can look similar to another urgent problem, and horses should not be monitored at home for long when those signs appear.

Cyproheptadine can interact with other medications that affect the brain, serotonin pathways, or sedation level. Your vet will want to know about every prescription, supplement, calming product, and over-the-counter medication your horse receives. That includes antihistamines, sedatives, pain medications, reproductive hormones, and any compounded products.

Use extra caution when cyproheptadine is combined with other drugs that may cause sleepiness or slowed gut motility. In theory and in other species, anticholinergic and central nervous system effects can add up. That does not always mean the combination is unsafe, but it does mean your vet may want a lower starting dose or closer monitoring.

Because cyproheptadine is sometimes used alongside pergolide in horses with PPID, it is important not to assume that adding another endocrine medication is harmless. Combination therapy may be reasonable in selected cases, but it should be based on your vet's exam findings, lab results, and treatment goals. If your horse competes, also ask about medication rules and withdrawal guidance before starting any new drug.